Literature DB >> 6933271

Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.

E Gorelik, S Segal, M Feldman.   

Abstract

Studies were made of the growth of metastases of the 3LL Lewis lung carcinoma in tumor-bearing and tumor-excised C57BL/6 mice after intrafootpad inoculation of different cell doses to the intact or immunosuppressed host. The total metastatic volume was higher in tumor-bearing mice given transplants of low doses of 3LL cells (3 X 10(4)- 1 X 10(5)) than in mice receiving high doses of cells (1 X 10(6)-5 X 10(6)). The growth of postoperative lung metastases depends on the size of the removal of local tumors and the rate of their development. Surgical removal of small, medium, or large local tumors, respectively, resulted in the development of smaller, similar, or larger volumes of pulmonary metastases compared to the metastases in tumor-bearing mice not having surgery. Accelerated growth of postoperative metastases in mice inoculated with low doses of 3LL cells was observed following removal of the local tumors of more than 310 mm3. The same effect was observed on mice given transplants of high doses of 3LL cells only when the removed local tumors had reached a volume of more than 550 mm3. In immunologically suppressed tumor-bearing mice, acceleration of the metastatic growth in the lungs was observed independently of the inoculum size. Even in the immunosuppressed mice, the growth of metastases was not optimal, and an additional stimulus for their growth was achieved following the removal of local tumors. This finding suggested that immunologic and nonimmunologic mechanisms were involved in the control of the metastatic growth of 3LL tumors in mice.

Entities:  

Mesh:

Year:  1980        PMID: 6933271

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  23 in total

1.  Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas.

Authors:  M Murata; M Nakagawa; S Takahashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.

Authors:  Mayrel Labrada; Isabel Pablos; Francesca Prete; Giselle Hevia; Marilyn Clavell; Federica Benvenuti; Luis E Fernández
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model.

Authors:  B Rashidi; M Yang; P Jiang; E Baranov; Z An; X Wang; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells.

Authors:  P Brodt; M Feldman; S Segal
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Interactions between the local tumor and its metastases.

Authors:  E Gorelik; S Segal; J Shapiro; S Katzav; Y Ron; M Feldman
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Immunologic enhancement of experimental metastasis in the rat.

Authors:  J R Starkey; S S Ristow; T L McDonald; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 8.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

9.  Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.

Authors:  Y Umeda; A Sakamoto; J Nakamura; H Ishitsuka; Y Yagi
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.

Authors:  J Shapiro; J Jersky; S Katzav; M Feldman; S Segal
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.